- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Recent updates on allogeneic CAR-T cells in hematological malignancies ; volume:24 ; number:1 ; day:3 ; month:9 ; year:2024 ; pages:1-22 ; date:12.2024
Cancer cell international ; 24, Heft 1 (3.9.2024), 1-22, 12.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Mansoori, Shafieeh
Noei, Ahmad
Maali, Amirhosein
Seyed-Motahari, Seyedeh Sheila
Sharifzadeh, Zahra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03479-y
- URN
-
urn:nbn:de:101:1-2411261054437.983278027508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mansoori, Shafieeh
- Noei, Ahmad
- Maali, Amirhosein
- Seyed-Motahari, Seyedeh Sheila
- Sharifzadeh, Zahra
- SpringerLink (Online service)
Ähnliche Objekte (12)
The journey of CAR-T therapy in hematological malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
The journey of CAR-T therapy in hematological malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
The journey of CAR-T therapy in hematological malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Deubiquitinases in hematological malignancies
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies